Sichuan, China

Yongxu Huo


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):

Title: The Innovative Contributions of Yongxu Huo in Cancer Research

Introduction

Yongxu Huo, an accomplished inventor based in Sichuan, China, has made significant strides in the field of cancer research. His innovative work has led to the development of a patent that shows promise in treating serious cancers, including prostate and breast cancer. His dedication to advancing medical science is evident through his contributions at Hinova Pharmaceuticals Inc.

Latest Patents

Yongxu Huo holds a patent for a BRD4 inhibitor along with a preparative method and its uses. The compound, defined by the formula (I), demonstrates a strong inhibitory effect on the proliferation of human prostate cancer cells (CWR22RV1) and breast cancer cells. Furthermore, when combined with an androgen receptor inhibitor, HC-1119, the compound significantly enhances its effectiveness against prostate cancer cells. This innovative agent can be utilized independently or in conjunction with other antineoplastic agents, providing a potential treatment with heightened therapeutic impacts on challenging cancers.

Career Highlights

Throughout his career at Hinova Pharmaceuticals Inc., Yongxu Huo has focused on developing therapeutic agents aimed at combating cancer. His research has paved the way for novel treatment strategies that are crucial for patients struggling with prostate and breast cancer. His dedication to improving cancer treatments reflects his commitment to the field.

Collaborations

Yongxu Huo has worked closely with prominent colleagues such as Lei Fan and Fei Wang, collaborating on projects that push the boundaries of cancer research. Together, they share the common goal of advancing the development of effective medications that target cancer therapies.

Conclusion

In conclusion, Yongxu Huo has made significant contributions to cancer treatment through his innovative patent for a BRD4 inhibitor. His work at Hinova Pharmaceuticals Inc. exemplifies the critical role of inventors in medical research and the potential to enhance therapeutic strategies against devastating diseases such as prostate and breast cancer. His ongoing efforts will undoubtedly leave a lasting impact on the future of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…